Socioeconomic factors increase mortality after lung cancer surgery

the ONA take:

According to a new study published online in the Journal of the American College of Surgeons, patients with limited education and low income have a greater risk of death within 30 days after undergoing surgery for lung cancer than those who are more educated and have more money.

For the study, researchers analyzed data from over 215,000 lung cancer operation admissions. Results showed that living in lower income households and in less-educated communities were independently associated with higher short-term postoperative mortality, in addition to other factors, including male gender, older age, late-stage cancer, multiple co-morbidities, and larger tumor size.

Specifically, those who resided in communities with a median household income of less than $30,000 had a 25% increased risk of dying after surgery within 30 days. Patients from less-educated communities had a 16% increased risk of death within 30 days compared with those from more educated communities.

"In order to get uniform superior outcomes for our patients, we need to identify the patients who are at risk for worse outcomes," said study co-author Felix G. Fernandez, MD, FACS, a lung surgeon and an assistant professor of surgery at Emory University School of Medicine. Atlanta. "This is the first step in describing where those disparities exist."

Effective management of dietary cholesterol may prevent metastasis in patients with prostate cancer
Patients with limited education and low income have a greater risk of death within 30 days after undergoing surgery for lung cancer.
People with limited education and low income have higher odds of death within 30 days after undergoing an operation for lung cancer than those who are more educated and financially better off.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs